Biotech Food Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Sep
14
2023
Stark Integrity Podcast: FCA, CARES Act, and Call Arrangements Episodes [Podcast] Nelson Mullins
Sep
14
2023
NNCO Will Host Symposium on “Enabling the Nanotechnology Revolution” on October 10, 2023 Bergeson & Campbell, P.C.
Sep
14
2023
Key Takeaways | Hospital and Health System Digital Health Spotlight: It’s all About the Patient! McDermott Will & Emery
Sep
14
2023
Back to FAST Recovery: Business and Labor Reach Agreement Jackson Lewis P.C.
Sep
13
2023
FDA Sponsors Workshops on the Use of Meta-Analyses in Nutrition Research and Policy Keller and Heckman LLP
Sep
13
2023
Sua Sponte State Law Certification in Opioid MDL Appeal Squire Patton Boggs (US) LLP
Sep
12
2023
HHS Recommends Re-Classification of Marijuana as a Schedule III Controlled Substance – A Bellwether for the Future of Cannabis-ness Epstein Becker & Green, P.C.
Sep
12
2023
It’s Time to Move On: Litigation Regarding Alabama Medical Cannabis Commission Needs to Come to a Head Bradley Arant Boult Cummings LLP
Sep
12
2023
Another Heavy Metal Lawsuit Dismissed Keller and Heckman LLP
Sep
11
2023
DTC Promotional Labeling and Advertisements: Quantitative Efficacy Wins Over FDA in Final Guidance on Presenting Risk Information Foley & Lardner LLP
Sep
11
2023
Old North State Report – Sept. 11, 2023 Nelson Mullins
Sep
11
2023
FDA Issues Draft Guidance on Best Practices for Selecting Predicate Devices for 510(k) Notifications ArentFox Schiff LLP
Sep
11
2023
California Steps Up Liquor License Enforcement McDermott Will & Emery
Sep
8
2023
DOE and NSF Select Three Projects to Accelerate Biomanufacturing Innovation and Advance the U.S. Bioeconomy Bergeson & Campbell, P.C.
Sep
8
2023
Food & Chemicals Unpacked: The Notorious NAD: Challenge Accepted? Keller and Heckman LLP
Sep
8
2023
California Senate Removes Titanium Dioxide from AB 418 List of Prohibited Substances Keller and Heckman LLP
Sep
8
2023
FDA Issues Final Guidance on Informed Consent in Clinical Investigations McDermott Will & Emery
Sep
7
2023
France Reintroduces Bid to Ban Meat Names for Plant-Based Food Keller and Heckman LLP
Sep
7
2023
Context is Key: FDA Sends a Strong Message About Efficacy Claims Sheppard, Mullin, Richter & Hampton LLP
Sep
7
2023
EPA Posts Resources on Rule to Accelerate Use of PIPs Bergeson & Campbell, P.C.
Sep
6
2023
The Great Divide: The Feds’ Differing Approach to Psychedelics and Cannabis Bradley Arant Boult Cummings LLP
Sep
6
2023
Decentralized Clinical Trials: Sponsor Responsibilities Foley & Lardner LLP
Sep
5
2023
FDA Updates Seafood List Guidance Keller and Heckman LLP
Sep
5
2023
Unpacking Averages: How Accurate Do Class II Medical Devices Need to Be to Obtain 510(k) Clearance? Epstein Becker & Green, P.C.
Sep
5
2023
Unpacking Averages: How Accurate Do Class II Medical Devices Need to Be to Obtain 510(k) Clearance? Epstein Becker & Green, P.C.
Sep
5
2023
FDA Issues Final Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors Epstein Becker & Green, P.C.
Sep
5
2023
State Regulation of Pharmacy Benefit Managers: Tenth Circuit Holds That ERISA and Medicare Part D Preempt Key Parts of Oklahoma PBM Law Epstein Becker & Green, P.C.
Sep
1
2023
CMS Names Its First Ten Negotiated Part D Drugs: Inflation Reduction Act Updates Epstein Becker & Green, P.C.
Sep
1
2023
Seventh Circuit Follows Illinois Supreme Court Precedent and Finds BIPA Claims Timely Vedder Price
Sep
1
2023
Reclassifying Cannabis as a Schedule III Substance – Will the DEA Agree? Sheppard, Mullin, Richter & Hampton LLP
Sep
1
2023
Kraft Heinz Agrees to Settle Suit Over Malic Acid Flavoring Keller and Heckman LLP
Sep
1
2023
Alabama Medical Cannabis Licensing Program Halted (Again): Is the Levee Goin’ to Break? Bradley Arant Boult Cummings LLP
Sep
1
2023
Medical Supplier Agrees to Pay $29 Million for FCA Violations ArentFox Schiff LLP
Aug
31
2023
Two New Drug Supply Chain Security Act Guidance to Help Pharmaceutical Supply Chain Partners Comply with the DSCSA’s Move to Electronic Tracking Nelson Mullins
Aug
31
2023
FDA Issues Warning Letters to Three Infant Formula Manufacturers Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins